Philip Ashman

COO & SVP, Commercial Operations Europe at Alimera Sciences

Philip Ashman is the Chief Operating Officer, SVP, Commercial Operations Europe at Alimera Sciences. Philip has held this position since December 2011. Prior to this, they were the Vice President, Head Global Launch Team (Oncology) at Bayer Schering Pharma from January 2010 to December 2011. From October 2008 to January 2010, they were the Vice President, Head Regional Business Unit - Oncology - Region Europe/Canada at Bayer Schering Pharma. From April 2006 to September 2008, they were the Business Unit Head - Oncology UK at Bayer Schering Pharma. From March 2005 to March 2006, they were the Head of Environment and Access at AstraZeneca. From January 2001 to December 2003, they were the Head of CNS BU at sanofi-aventis. From January 1995 to December 1997, they were the Product Manager at Schering-Plough Pharmaceuticals. From January 1994 to December 1995, they were the Hospital Sales Representative at Schering-Plough Pharmaceuticals. From January 1993 to March 1994, they were the Senior Clinical Research Associate at Schering-Plough Pharmaceuticals. From January 1992 to December 1992, they were the Clinical Research Associate at Warner Lambert.

Philip Ashman has a PhD in Biochemistry from Royal Holloway, University of London and a BSc in Biochemistry from UCL.

They are on a team with David Holland - Chief Marketing Officer, SVP Corporate Communications and Managed Markets, Phil Jones - Chief Financial Officer, and David Dyer M.d. - Chief Retina Specialist. Philip Ashman reports to Rick Eiswirth, President and Chief Executive Officer.

Links

Previous companies

Bayer logo
Merck logo
AstraZeneca logo
Sanofi logo

Timeline

  • COO & SVP, Commercial Operations Europe

    Current role

View in org chart